Periarthritis Clinical Trial
Official title:
A Validation Study of Sodium Hyaluronate in Patients With Periarthritis of Shoulder
Alge as a positive control drug, in patients with periarthritis of shoulder, in a double-blind, controlled manner to study the safety and treatment of Sodium Hyaluronate
Aerzhi as a positive control drug, in patients with periarthritis of shoulder, in a double-blind, controlled manner to study the safety and treatment of Sodium Hyaluronate. Once a week, continuous treatment for 5 weeks ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01807962 -
Local Injection Under US Control in GTPS.
|
Phase 3 |